News Digest / Income Statements / Best Buy Q2: revenue up, online and Canada growth offset by restructuring and Health exit

Best Buy Q2: revenue up, online and Canada growth offset by restructuring and Health exit

StockInvest.us
05:01pm, Friday, Sep 05, 2025
Illustration by StockInvest.us

Best Buy Co., Inc. (NYSE: BBY) - What's happening inside

- Q2 fiscal 2026 results show revenue resilience but profit hit by restructuring:
* Revenue (three months ended Aug 2, 2025): $9,438 million (up 1.6% YoY).
* Comparable sales (Q2): +1.6%; Six months: +0.4%.
* Operating income (Q2): $251 million vs $383 million year-ago - decline driven largely by restructuring charges.
* Net earnings (Q2): $186 million; Diluted EPS: $0.87 (down from $1.34).

- Restructuring and one-time items are the main negative drivers this quarter:
* Restructuring charges: $114 million in Q2; $223 million for six months.
* Loss on disposal of a Best Buy Health component recorded; related impairments include a $16 million indefinite-lived intangible write-off this quarter and prior goodwill impairment of $475 million (FY25) for Best Buy Health.

- Income statement positives and operational strengths:
* Gross profit (Q2): $2,194 million (gross margin 23.2%, only modestly below prior-year 23.5%).
* Domestic segment remains the revenue engine: Domestic revenue Q2 $8,698M; online revenue Q2 $2,856M (online mix 32.8%; comparable online sales +5.1%).
* International (Canada) growth: Q2 revenue $740M, comparable sales +7.6% (gaming, computing, mobile phones driving strength).
* Operating cash flow (six months): $783M - supports dividends, buybacks and capex.

- Balance sheet and liquidity highlights (conservative profile):
* Cash & cash equivalents (Aug 2, 2025): $1,456M; total cash+restricted cash on hand: $1,713M.
* Inventories: $5,816M (up from $5,085M at Feb 1, 2025) - watch working capital build and category mix.
* Total assets: $15,253M; Total equity: $2,716M (down from $3,107M Aug 3, 2024).
* Long-term debt (carrying): $1,164M (less current portion).
* New Five-Year Revolving Credit Facility: $1.25B available (undrawn as of Aug 2, 2025).

- Capital allocation and returns to shareholders:
* Six months repurchases: $167M (2.5M shares); average price $66.03 YTD; Q2 repurchase cost $67M at $68.65 avg.
* Dividends paid (six months): $403M; regular dividend per share $0.95 (Q2).
* Remaining repurchase authorization: ~$3.118B available under board program.

- Cash flow and spending discipline:
* Six-month capex: $341M (planned investments continue; Q2 capex $175M).
* Cash used in financing (six months): $574M (repurchases + dividends).
* Net decrease in cash for the six months: $155M. Management says liquidity is sufficient for near-term needs.

- Operational changes and risks inside the company:
* New restructuring initiative (Fiscal 2026 Labor & Store Optimization) to align field resources, close select non-traditional locations and redirect corporate resources - expected to reduce some stores and related workforce; management doesn't expect material future charges beyond current guidance.
* Best Buy Health business being optimized; a component was exited - this triggered impairments and disposal losses.
* Inventory mix shifts and lower product margins pressured gross profit rate slightly; appliances and home theater categories showing weakness while computing, gaming and mobile are strong.
* Tariff exposure and vendor sourcing remain a watch item (management actively shifting sourcing).

- Key metrics and facts (straight numbers to watch):
* Revenue Q2: $9,438M; Six months revenue: $18,205M.
* Cost of sales Q2: $7,244M; Gross profit Q2: $2,194M (23.2%).
* SG&A Q2: $1,829M (19.4% of revenue).
* Restructuring charges Q2: $114M (Q2 operating income margin fell to 2.7% from 4.1% a year ago).
* Net earnings six months: $388M; diluted EPS six months: $1.82 vs $2.47 prior-year six months.
* Shares outstanding: ~210.4 million (Aug 2, 2025).

- Bottom line - what investors and stakeholders should take away:
* Best Buy is showing revenue resilience and healthy online & international pockets of growth, with solid operating cash generation.
* Near-term profitability is weighed down by restructuring and portfolio clean-ups (Best Buy Health exit, store optimization) plus margin pressure in some product categories.
* Balance sheet and liquidity remain conservative: meaningful cash, modest leverage, undrawn credit capacity and ongoing returns to shareholders via dividends and buybacks.
* Watch upcoming holiday (Q4) performance, execution of the restructuring (cost savings vs. one-time charges), inventory trends and margin recovery for the next meaningful read on earnings momentum.

Sources: Best Buy Form 10-Q for quarter ended August 2, 2025 - selected tables and notes.

About The Author

StockInvest.us

StockInvest.us is a stock market research tool that provides daily stock signals and technical analysis for over 25 000 tickers on 38 exchanges. The company was founded in 2016 in Vilnius, Lithuania.

Trusted Broker
Start Your Journey With:
eToro
0% Commission Stock Trading
Follow Other Investors Strategy
Wide variety: Crypto, stocks, ETFs

Securities trading offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk.